The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction.

Saved in:
Bibliographic Details
Title: The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction.
Authors: Acquarone E; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, New York, NY, USA., Argyrousi EK; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, New York, NY, USA., Arancio O; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, New York, NY, USA.; Department of Internal Medicine, Columbia University, New York, NY, USA.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA., Watterson DM; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Roy SM; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Source: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2024; Vol. 98 (4), pp. 1349-1360.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 9814863 Publication Model: Print Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-8908
DOI:10.3233/JAD-240063